Investors finally get a glimpse of Agile Therapeutics Inc. (AGRX) volume hitting the figure of 0.92 million.

A new trading day began on January 23, 2023, with Agile Therapeutics Inc. (NASDAQ: AGRX) stock priced at $0.304, up 5.86% from the previous day of trading. During the day, the shares moved up to $0.304 and dropped to $0.28 before settling in for the closing price of $0.28. AGRX’s price has ranged from $0.17 to $15.60 over the past 52 weeks.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Meanwhile, its annual earnings per share averaged -26.00%. With a float of $36.81 million, this company’s outstanding shares have now reached $37.00 million.

The extent of productivity of a business whose workforce counts for 30 workers is very important to gauge. In terms of profitability, gross margin is -32.11, operating margin of -1731.41, and the pretax margin is -1826.24.

Agile Therapeutics Inc. (AGRX) Insider and Institutional Ownership

As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Agile Therapeutics Inc. is 0.20%, while institutional ownership is 5.70%. The most recent insider transaction that took place on Aug 26, was worth 22,500. In this transaction Chief Executive Officer of this company bought 50,000 shares at a rate of $0.45, taking the stock ownership to the 64,343 shares.

Agile Therapeutics Inc. (AGRX) Latest Financial update

In its latest quarterly report, released on 6/29/2022, the company reported earnings of -$2.71 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). This company achieved a net margin of -1826.24 while generating a return on equity of -255.62. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.27 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -26.00% per share during the next fiscal year.

Agile Therapeutics Inc. (NASDAQ: AGRX) Trading Performance Indicators

Here are Agile Therapeutics Inc.’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.20. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.44.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -14.93, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -0.67 in one year’s time.

Technical Analysis of Agile Therapeutics Inc. (AGRX)

The latest stats from [Agile Therapeutics Inc., AGRX] show that its last 5-days average volume of 0.78 million was inferior to 1.02 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 37.22%. Additionally, its Average True Range was 0.03.

During the past 100 days, Agile Therapeutics Inc.’s (AGRX) raw stochastic average was set at 47.98%, which indicates a significant decrease from 78.55% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 99.05% in the past 14 days, which was higher than the 95.95% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $0.2228, while its 200-day Moving Average is $1.0332. Now, the first resistance to watch is $0.3069. This is followed by the second major resistance level at $0.3175. The third major resistance level sits at $0.3309. If the price goes on to break the first support level at $0.2829, it is likely to go to the next support level at $0.2695. The third support level lies at $0.2589 if the price breaches the second support level.

Agile Therapeutics Inc. (NASDAQ: AGRX) Key Stats

With a market capitalization of 12.07 million, the company has a total of 40,615K Shares Outstanding. Currently, annual sales are 4,100 K while annual income is -74,890 K. The company’s previous quarter sales were 3,000 K while its latest quarter income was -19,670 K.

Latest

On What Basis Did Swvl Holdings Corp (SWVL) Stock Rise 47% Pre-Hours?

When last checked, Swvl Holdings Corp. (Nasdaq: SWVL), a...

What Drove Organovo (ONVO) Stock Up 15% In After-Hour Session On Tuesday?

Shares of Organovo Holdings Inc. (Nasdaq: ONVO) were up...

Is There Any Reason As To Why The Zai Lab (ZLAB) Stock Expanded By 13%?

The biopharmaceutical business Zai Lab Limited (NASDAQ: ZLAB), which...

Newsletter

 

Don't miss

Wearable Devices (WLDS) Stock Rose 12% On Tuesday, But On What Basis?

Wearable Devices Ltd (NASD: WLDS) is experiencing significant growth...

Did Anything Boost ObsEva (OBSV) Stock In Pre-Hours Trading?

Following an update, shares of ObsEva SA (NASD: OBSV)...

How Did The Kalera (KAL) Stock Rise 32% Pre-Hours?

At the time of the most recent check, shares...

Why Has Selina Hospitality (SLNA) Stock Increased In Extended Session On Friday?

The stock of Selina Hospitality PLC (NASD: SLNA), which...

Do You Know Why Evolv Technologies (EVLV) Stock Surged Nearly 10% Today?

Today's charts show Evolv Technologies Holdings Inc. (Nasdaq: EVLV)...

No matter how cynical the overall market is OncoSec Medical Incorporated (ONCS) performance over the last week is recorded -25.00%

OncoSec Medical Incorporated (NASDAQ: ONCS) open the trading on February 02, 2023, with a bit cautious approach as it glided -23.94% to $1.62. During...

Kiromic BioPharma Inc. (KRBP) is heading in the right direction with an average volume of $748.72K

Witnessing the stock’s movement on the chart, on February 02, 2023, Kiromic BioPharma Inc. (NASDAQ: KRBP) set off with pace as it heaved 7.42%...

Vroom Inc. (VRM) is heading in the right direction with an average volume of $4.26M

Vroom Inc. (NASDAQ: VRM) established initial surge of 11.02% at $1.41, as the Stock market unbolted on February 02, 2023. During the day, the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here